OP-8 SECOND LINE THERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADECUATE RESPONSE: ARE WE CHOOSING THE RIGHT TARGET POPULATION FOR CLINICALS TRIALS?
Conflict of interest: No Introduction and Objectives: Identification of primary biliary cholangitis (PBC) patients who could benefit from second line therapy is uncertain. Most trials rely on 12 month UDCA response assessed by POISE criteria.Evaluate eligible patients and identify epidemiological-cl...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Annals of Hepatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268124003892 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|